beta
Trial Radar IA

Mostrando gli studi clinici che corrispondono al luogo: Stati Uniti.

Posso aiutarti a capire le condizioni di salute, i trattamenti o a trovare studi clinici vicini.
Il nostro strumento di ricerca supporta solo l'inglese. Per la ricerca e la discussione in altre lingue, usa Trial Radar IA sopra o seleziona i filtri per condizione medica e luogo (qui sotto).
236 risultati trovati
Primi 50 visualizzati
 
Stato (Predefinito)
Non Ancora in Arruolamento, In Arruolamento, Attivo, Non in Arruolamento
×
 
Luogo
Stati Uniti
×
 
Intervento
GLP-1
×
 
Titolo dello studio
Stato
Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy (DINE-GLP1) NCT07313384
In arruolamento
Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema NCT07012642
In arruolamento
Impact GLP-1 Agonists Following Bariatric NCT06132477
In arruolamento
GLP-1 RA on Liver OMICS in MASLD NCT06982378
Non ancora in arruolamento
Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial NCT07111494
Non ancora in arruolamento
GLP-1 and Hypoglycemia NCT01858896
Attivo, non in arruolamento
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists NCT07207148
In arruolamento
Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication NCT06843512
In arruolamento
Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy NCT07175805
Non ancora in arruolamento
Combination Therapy for Alcohol Use Disorder NCT07249554
Non ancora in arruolamento
Assess Impact of Poly-L-lactic Acid on GLP1 Subjects NCT07217743
Non ancora in arruolamento
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring NCT06668935
In arruolamento
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists NCT07325435
Attivo, non in arruolamento
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy NCT06903923
In arruolamento
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) NCT07480109
Non ancora in arruolamento
RESCUE: interruzione di GLP-1 NCT07190794
In arruolamento
Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists NCT07221461
Non ancora in arruolamento
Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia NCT06654219
In arruolamento
Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists NCT07006142
In arruolamento
Beta-cell Response to Incretin Hormones in Cystic Fibrosis NCT01851694
In arruolamento
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists NCT07224880
In arruolamento
The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality NCT07127354
In arruolamento
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes (PRECIDENTD) NCT05390892
In arruolamento
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes NCT06967558
In arruolamento
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes (GLOW) NCT07428746
Non ancora in arruolamento
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery NCT00992901
In arruolamento
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (CER-4-T2D) NCT05220917
Attivo, non in arruolamento
Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions (COMO-1) NCT06867718
Attivo, non in arruolamento
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans NCT06972407
Non ancora in arruolamento
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse NCT07419854
In arruolamento
Stanford Pediatric Healthy Weight Index NCT07316816
In arruolamento
Effect of Supplement on Appetite and GLP-1 (GLP-1 Suppleme) NCT06790771
Non ancora in arruolamento
MAINTAIN (Mucosal AblatIoN Therapy After INcretins) NCT06734312
In arruolamento
Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk (SIPPA-QH_HHC-2) NCT07032311
Non ancora in arruolamento
Comparison of Body Composition Changes With Weight Loss Interventions (REFORM) NCT07115069
In arruolamento
Strength Training Response of Muscle in GLP-1 Users (STRONG-GLP) NCT07104539
In arruolamento
A Study of a Weight Loss Intervention in People With Endometrial Cancer NCT06751589
In arruolamento
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS) NCT07169136
In arruolamento
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM (VESPER-2) NCT06897202
Attivo, non in arruolamento
GLP-1R Actions on Muscle and the Skeleton (GRAMS) NCT07154719
Non ancora in arruolamento
Lifestyle Change Implementation Research Network at PRC at UMass Chan (LCIRN) NCT07481305
Non ancora in arruolamento
A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight (VESPER-1) NCT06712836
Attivo, non in arruolamento
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants NCT06737042
Non ancora in arruolamento
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity (BMT-801) NCT06565611
Attivo, non in arruolamento
Weight Loss Management in Endometrial Cancer Survivors (ECS Weight) NCT06877572
In arruolamento
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity NCT07091500
In arruolamento
Residual Gastric Content and GLP-1 NCT06814080
In arruolamento
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes NCT06976619
In arruolamento
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes NCT05119179
In arruolamento
A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health NCT06911073
In arruolamento